4
Changes in Ownership
Protagenic Therapeutics, Inc.\new Filed Acc 0001493152-20-003039
Options or other derivatives
- Director acquired 120,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Silverman Joshua Director | 2020-02-21 | Grant or award · PTIX Common stock Options | +120,000 | 120,000 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…